Avedro says it paid an unspecified amount for Swiss ophthalmology firm Iroc Innocross and its corneal cross-linking technology.
Avedro said today that it augmented its corneal cross-linking capabilities with the acquisition of a Swiss ophthalmology firm, Iroc Innocross AG, for an unspecified amount.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1t08SCv
Cap comentari:
Publica un comentari a l'entrada